Brain Fingerprinting Laboratories HQ Moves to Seattle

Seattle, Washington. (January 31, 2004)  Brain Fingerprinting Laboratories, Inc. announced today that it has established a new Headquarters and Research and Development Office in Seattle, Washington. The office will also serve as the company's regional operations center for the Western US. The Research and Development laboratory will be located in the Washington Technology Center on the campus of The University of Washington. The Economic Development Council of Seattle and King County along with the City of Seattle's Office of Economic Development and the King County's Executive Office worked diligently with Brain Fingerprinting officials to recruit the company to the Seattle area.

Dr. Lawrence Farwell, a Seattle born neuroscientist, invented the Brain Fingerprinting^® technology.  Brain Fingerprinting testing can help authorities to determine the truth regarding a crime, terrorist act, or terrorist training by detecting information stored in the brain.

TIME Magazine selected Dr. Farwell to the TIME100: The Next Wave, the 100 Innovators who may be "the Picassos or the Einsteins of the 21st Century."

Brain Fingerprinting technology has been found to be 100% accurate to date in tests funded by the CIA and in tests for the FBI and US Navy.  Brain Fingerprinting testing has been ruled admissible in court as scientific evidence in Iowa. This new technology has helped to exonerate and free a man imprisoned for 27 years for a murder he did not commit and to put a serial killer in prison for life.

The patented Brain Fingerprinting technology accurately measures brain-wave responses to words or pictures presented on a computer screen. A subject who has knowledge of the information being tested emits a specific, measurable response known as a P300/MERMER.  A subject who lacks this record in his brain does not emit the response.  Thus, the technology can accurately distinguish between an innocent person and a criminal or terrorist by detecting knowledge of a crime in the brain of a perpetrator or knowledge of terrorist training in the brain of a terrorist.

Brain Fingerprinting Laboratories, Inc. has also applied for patent protection for a brain-wave test to detect Alzheimer's disease and measure the efficacy of drugs and other treatment options.  Even a rudimentary first generation test protocol has been shown to detect Alzheimer's as accurately as today's highly expensive and subjective clinical judgment protocols and currently available tests.  The company estimates that when finalized and validated and approved by the Food and Drug Administration, the test will cost less than 25% of other diagnostic alternatives.  The test equipment will be easily run by a nurse or trained technician in any doctor's office in the world.  The test will give a diagnosis in less than 1/2 hour.

The company, has its National Data Center and Midwest regional operations in Iowa and a regional operations center in Washington D.C.

TOP        PRESS RELEASES        HOME